Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatmentTomohiro Yabushita, Susumu Goyama, Ruka Shimura et al.|Cell Reports|2023Cited by 28
Mitotic Perturbation Is a Key Mechanism of Action of Decitabine in Myeloid Tumor TreatmentTomohiro Yabushita, Susumu Goyama, Takumi Chinen et al.|Blood|2022Cited by 3